Bank of America’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bank of America’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,501	Closed	-$63K	–	7574
2017 Q3	$63K	Sell	10,501 -4,452	-30%	-$11.5K	﹤0.01%	5854
2017 Q2	$22K	Buy	14,953 +3,288	+28%	+$4.47K	﹤0.01%	6206
2017 Q1	$21K	Buy	11,665 +9,986	+595%	+$26.5K	﹤0.01%	6305
2016 Q4	$7K	Buy	1,679 +1,172	+231%	+$6.24K	﹤0.01%	6653
2016 Q3	$4K	Sell	507 -1,367	-73%	-$9.88K	﹤0.01%	6717
2016 Q2	$11K	Buy	+1,874	New	+$14.3K	﹤0.01%	6479
2016 Q1	–	Sell	-135	Closed	-$2K	–	7795
2015 Q4	$2K	Buy	+135	New	+$1.71K	﹤0.01%	7162

Bank of America's DMTX Position: Q4 2017 in Review

Bank of America sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 10,501 shares — an estimated $63K sold.

Bank of America first reported a position in DMTX in Q4 2015 and held it in 7 quarters. The position peaked at $63K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Bank of America reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Bank of America sold 10,501 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $63K.
Bank of America first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 7 quarters.
Bank of America's Dimension Therapeutics, Inc position peaked at $63K in Q3 2017.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.